Annual report [Section 13 and 15(d), not S-K Item 405]

Note 7 - Stockholder's Equity (Tables)

v3.26.1
Note 7 - Stockholder's Equity (Tables)
12 Months Ended
Dec. 31, 2025
Notes Tables  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
   

For the year ended December 31,

 
   

2025

   

2024

 

Research and development

  $ 124     $ 269  

General and administrative

    541       967  

Total stock-based compensation expense

  $ 665     $ 1,236  
Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]
   

Number of Units and Awards

   

Weighted Average Grant Date Fair Value

 

Unvested balance at December 31, 2023

    1,311     $ 197.19  

Granted

    235,000       2.46  

Vested

    (283 )     85.50  

Unvested balance at December 31, 2024

    236,028     $ 3.44  

Forfeited

    (212 )     171.94  

Vested

    (416 )     85.50  

Unvested balance at December 31, 2025

    235,400     $ 3.19  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
   

Stock Options

   

Weighted Average Exercise Price

   

Weighted Average Remaining Contractual Term (in years)

   

Aggregate Intrinsic Value (in thousands)

 

Outstanding as of December 31, 2023

    22,474     $ 85.5000       9.50     $  

Granted

    234,000       2.46       10.00     $  

Outstanding as of December 31, 2024

    256,474     $ 9.74       9.62     $  

Outstanding as of December 31, 2025

    256,474     $ 9.74       8.62     $  

Expected to vest

    162,624     $ 5.84       8.68     $  

Vested and Exercisable as of December 31, 2025

    93,850       16.48       8.52     $  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

For the Year Ended December 31,

 
   

2024

 

Risk-free interest rate

    3.6 %

Expected dividend yield

     

Expected term in years

    5.6  

Expected volatility

    135.0 %
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
   

Warrants

   

Weighted Average Exercise Price

   

Aggregate Intrinsic Value (in thousands)

 

Outstanding, December 31, 2023

    524,601     $ 32.42     $ 1  

Granted

    1,861,817     $ 6.23        

Exercised

    (910,218 )   $ 10.16        

Outstanding, December 31, 2024

    1,476,200     $ 8.64     $  

Expired

    (703,459 )   $ 6.52        

Outstanding, December 31, 2025

    772,741     $ 10.56     $  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
   

December 31,

   

December 31,

 
   

2025

   

2024

 

Stock price

  $ 0.68     $ 2.00  

Risk-free interest rate

    3.75 %     4.27 %

Expected dividend yield

           

Expected term in years

    1.78       2.80  

Expected volatility

    151 %     155 %
Warrant [Member]  
Notes Tables  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
   

January 2023

   

New Series A

   

New Series B

 
   

Warrants

   

Warrants

   

Warrants

 

Stock price

  $ 14.25     $ 14.25     $ 14.25  

Risk-free interest rate

    4.40 %     4.02 %     4.40 %

Expected dividend yield

                 

Expected term in years

    2.1       5.0       1.5  

Expected volatility

    185 %     138 %     187 %
   

October 2022

   

November 2023

   

January 2024

   

Series C

   

Series D

   

Placement Agent

 
   

Warrants

   

Warrants

   

Warrants

   

Warrants

   

Warrants

   

Warrants

 

Stock price

  $ 4.76     $ 4.76     $ 4.76     $ 4.76     $ 4.76     $ 4.76  

Risk-free interest rate

    4.79 %     4.64 %     4.64 %     4.64 %     4.96 %     4.64 %

Expected dividend yield

                                   

Expected term in years

    3.4       4.5       4.7       5.0       1.5       5.0  

Expected volatility

    160 %     148 %     145 %     141 %     132 %     141 %